ProjectDEPECA-1
Basic data
Title:
DEPECA-1
Duration:
09/10/2025 to 09/10/2030
Abstract / short description:
DEPECA- DEfeating PEnile CAncer- A Phase II study to evluate a first-line systemic therapy with antibody-drug conjugate enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma
Involved staff
Managers
Department of Urology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Urology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Other staff
Department of Urology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Urology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Urology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Frankfurt am Main, Hessen, Germany